A carregar...
Liposomal adjuvant development for leishmaniasis vaccines
Leishmaniasis is a parasitic disease that ranges in severity from skin lesions to fatality. Since long-lasting protection is induced upon recovery from cutaneous leishmaniasis, development of an effective vaccine is promising. However, there is no vaccine for use in humans yet. It seems limited effi...
Na minha lista:
| Publicado no: | Ther Adv Vaccines |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5697592/ https://ncbi.nlm.nih.gov/pubmed/29201374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2051013617741578 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|